177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if 68Gallium-octreotate and 18Fluorodesoxyglucose
uptake, apparent diffusion coefficient and post 177Lu-octreotate SPECT/CT dosimetry are
reliable predictors for lesion-by-lesion treatment outcome.